TY  - JOUR
PY  - 2022//
TI  - Wishing to die or self-harm after stroke: a planned secondary analysis of the AFFINITY randomised controlled trial
JO  - Maturitas
A1  - Almeida, Osvaldo P.
A1  - Hankey, Graeme J.
A1  - Ford, Andrew
A1  - Etherton-Beer, Christopher
A1  - Flicker, Leon
A1  - Hackett, Maree
SP  - 86
EP  - 88
VL  - 166
IS  - 
N2  - We investigated the cumulative prevalence of self-harm ideation among stroke survivors of the AFFINITY trial. We assessed these thoughts with the last item of the PHQ-9, and functional impairment with the modified Rankin Scale (mRS). Of 1221 participants (age 63.9 ± 12.3 years, 775 men), 11 reported wishing to die or self-harm at baseline. By week 52, 36 of 1159 surviving participants had reported wishing to die or self-harm. Treatment with fluoxetine for 26 weeks did not change the prevalence of these thoughts compared with placebo. Clinically significant symptoms of depression were present in 95 % of participants with recurrent self-harm thoughts. The study was registered with the Australian and New Zealand Clinical Trials Registry, ACTRN12611000774921.<p />  <p>Language: en</p>
LA  - en
SN  - 0378-5122
UR  - http://dx.doi.org/10.1016/j.maturitas.2022.08.011
ID  - ref1
ER  -